Table 1. Preoperative patient characteristics.
| Patient characteristics | Data |
|---|---|
| Age, year, median (range) | 56 (43–66) |
| Gender, male/female, n (%) | 9/1 (90.0/10.0) |
| Single tumor (n=9) | |
| Diameter of tumor, cm, median (range) | 14.0 (5.2–17.0) |
| Multiple tumors (n=1) | |
| Number of lesions | 3 |
| Sum of diameters, cm | 19 |
| BCLC staging, n (%) | |
| A | 7 (70.0) |
| B | 1 (10.0) |
| C | 2 (20.0) |
| CNLC staging, n (%) | |
| Ib | 7 (70.0) |
| IIa | 1 (10.0) |
| IIIa | 2 (20.0) |
| METAVIR grade of liver fibrosis, n (%) | |
| Grade 2 (fibrosis) | 3 (30.0) |
| Grade 3 (fibrosis) | 1 (10.0) |
| Grade 4 (cirrhosis) | 6 (60.0) |
| Transient elastography, median (range) | 13.2 (5.1–16.4) |
| HBV-DNA, copies, median (range) | 17,100 (308–320,000) |
| Child-Pugh score, median (range) | 5 (5–5) |
| ICG-R15, median (range) | 5.1 (2.0–12.0) |
| MELD score, median (range) | 3.84 (1.30–10.10) |
BCLC, Barcelona Clinic Liver Cancer; CNLC staging, China Liver Cancer staging; HBV, hepatitis B virus; ICG-R15, indocyanine green 15-min retention test; MELD, model for end-stage liver disease.